Volta Labs, Watchmaker Genomics collaborate to launch Callisto Complete Kit for DNA EF Library Prep: Boston Wednesday, February 25, 2026, 18:00 Hrs [IST] At the Advances in Genome ...
Drug kingpin Nemesio “El Mencho” Oseguera Cervantes may be dead, but the Jalisco cartel he ran for years will likely outlive ...
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsElizabeth Krutoholow - Vice President of Investor ...
Transmission-scale AI campus structured for phased grid delivery as ERCOT faces record large-load interconnection ...
The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM).
For more than six decades, biomarker-based newborn screening has played a pivotal role in reducing infant mortality and ...
At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026 in Orlando, FL, Volta Labs, a leader in next-generation ...
Phase 1b translational data demonstrate localized ileocolonic target engagement, suppression of inflammatory and fibrotic gene programs, and early clinical response within seven days ...
After more than a century of monopoly control under Eskom, South Africa is shifting towards a competitive multi-market electricity system anchored by a wholesale market and supported by bilateral ...
An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up ...
Treatment approaches have shifted with the introduction of targeted agents, notably Bruton tyrosine kinase (BTK) inhibitors, as well as the emerging role of immunotherapy, according to a new review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results